Amneal Pharmaceuticals, Inc. Research And Development Expense

• Amneal Pharmaceuticals, Inc. showed a decrease of -2.4% in Research And Development Expense from 2024 to 2025.
• This data is from Amneal Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on February 27, 2026.
• XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 10 years of available data (2016 to 2025), Amneal Pharmaceuticals, Inc.'s Research And Development Expense has grown by 4.0%.
• Historical annual values: Fiscal year 2025: $186.18 million | Fiscal year 2024: $190.71 million | Fiscal year 2023: $163.95 million | Fiscal year 2022: $195.69 million | Fiscal year 2021: $201.85 million | Fiscal year 2020: $179.93 million | Fiscal year 2019: $188.05 million | Fiscal year 2018: $194.19 million | Fiscal year 2017: $171.42 million | Fiscal year 2016: $179.02 million.
• Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: June 20, 2026